Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression.
Marta LigeroGarazi SernaOmar S M El NahhasIrene SansanoSiarhei MauchanskiCristina ViaplanaJulien CalderaroRodrigo De Almeida ToledoRodrigo DienstmannRami S VanguriJennifer L SauterFrancisco Sanchez-VegaSohrab P ShahSantiago Ramón Y CajalElena GarraldaPaolo G NuciforoRaquel Perez-LopezJakob Nikolas KatherPublished in: Cancer research communications (2024)
The weakly supervised DL model to predict PD-L1 status from raw IHC data, integrating tumor staining intensity and morphology, enables enhanced patient stratification in cancer immunotherapy compared with traditional pathologist assessment.